Trial: 201606003

Improving risk assessment of AML with a precision genomic strategy to assess mutation clearance

Phase

II

Principal Investigator

Jacoby, Meagan

Disease Site

Acute Myeloid Leukemia (AML); Myeloid and Monocytic Leukemia

Learn more about this study at: clinicaltrials.gov